The following data is part of a premarket notification filed by Elucid Bioimaging Inc. with the FDA for Elucidvivo A.3.
Device ID | K221463 |
510k Number | K221463 |
Device Name: | ElucidVivo A.3 |
Classification | System, Image Processing, Radiological |
Applicant | Elucid Bioimaging Inc. 2 Park Plaza, Suite 700 Boston, MA 02116 |
Contact | Doug Shufelt |
Correspondent | Doug Shufelt Elucid Bioimaging Inc. 2 Park Plaza, Suite 700 Boston, MA 02116 |
Product Code | LLZ |
CFR Regulation Number | 892.2050 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Special |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2022-05-19 |
Decision Date | 2022-06-17 |
Device Identifier | submissionNumber | Supplement |
---|---|---|
B745ELUCIDVIVOA3 | K221463 | 000 |